Activity

Activity ID

4634

Expires

September 11, 2021

Format Type

Enduring

CME Credit

77.75

Fee

200
CME Provider

Interstate Postgraduate Medical Association

Description

*Clinician learners should be familiar with the current therapeutic strategies for suppressing disease activity and disability accumulation in individuals with radiologically isolated syndrome, relapsing-remitting multiple sclerosis, and progressive multiple sclerosis
*Clinician learners should have an overview of the roles of physical therapy, neurorehabilitation, and prosthetic/ robotic devices in the management of MS
*Clinician learners should be aware of the impact of current disease‐modifying therapies on specific neurological functions in individuals with MS
*Clinician learner should critically examine the efficacy of current disease‐modifying therapies across clinical subsets of individuals with MS
*Clinician learners should comprehend the current understanding of the role of innate immune cells in pathogenic and reparative pathways in MS
*Clinician learners should have a better understanding of the mechanisms of action of lymphocyte subsets in MS pathogenesis
*Clinician learners should know the highlights of the impact of MS on CNS resident cells, and therapeutic strategies to reverse CNS damage caused by MS
*Clinician learners should understand the relationship between the gut, microbiome, and disease activity in individuals with MS
*Clinician learner should have the updated information on the use of the emerging serological and cerebrospinal fluid biomarkers in the diagnosis, prognosis, and monitoring of individuals with MS
*Clinician learners should know the recent advances in imaging and visual system parameters in the diagnosis, prognosis, and monitoring of individuals with MS
*Clinician learners should know information on environmental, lifestyle, age‐related, and genetic/ epigenetic factors in MS risk and clinical course
*Clinician learners should understand the role of sex‐related factors in MS susceptibility, clinical course, and treatment
*Clinician learner should know the use of machine learning approaches in predicting MS risk and clinical course
*Clinician learner should know the diagnostic criteria, epidemiology, clinical manifestations, and treatment of neuromyelitis spectrum disorders and MOG antibody‐mediated disease

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
Yes

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

*Review current therapeutic strategies for suppressing disease activity and disability accumulation in individuals with radiologically isolated syndrome, relapsing remitting MS and progressive MS
*Review the roles of physical therapy, neurorehabilitation, and prosthetic/ robotic devices in the management of MS
*Integrate information about the impact of current disease modifying therapies on specific neurological functions in individuals with MS
*Critically examine the efficacy of current disease modifying therapies across clinical subsets of individuals
with MS
*Review the current understanding of the role of innate immune cells in pathogenic and reparative pathways in MS
*Critically examine the mechanisms of action of lymphocyte subsets in MS pathogenesis
*Synthesize information about the impact of MS on CNS resident cells, and therapeutic strategies to reverse CNS damage caused by MS
*Integrate studies on the relationship between the gut, microbiome, and disease activity in individuals with MS
*Critically examine data on the use of emerging serological and cerebrospinal fluid biomarkers in the diagnosis, prognosis and monitoring of individuals with MS
*Review advances in imaging and visual system parameters in the diagnosis, prognosis and monitoring of individuals with MS
*Integrate information on environmental, life style, agerelated, and genetic/ epigenetic factors in MS risk and clinical course
*Synthesize data on the role of sex related factors in MS susceptibility, clinical course and treatment
*Critically examine the use of machine learning approaches in predicting MS risk and clinical course
*Review advances on diagnostic criteria, epidemiology, clinical manifestations, and treatment of neuromyelitis spectrum disorders and MOG antibody‐mediated disease

Keywords

MS Research, Multiple Sclerosis Research, MS Education, Multiple Sclerosis Education

Competencies

Medical Knowledge, Patient Care & Procedural Skills

CME Credit Type

AMA PRA Category 1 Credit

Practice Setting

Academic Medicine, Inpatient, Outpatient, Physician Executives, Physician Scientists, Rural, Urban, VA/Military

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.